Melekoglu, Nuriye AsliOzdemir, HalisYasar, Seyma2024-08-042024-08-0420220009-92281938-2707https://doi.org/10.1177/00099228211059886https://hdl.handle.net/11616/100321The coronavirus disease 2019 (COVID-19) pandemic became an important public health problem affecting all age groups. The aim of this study was to evaluate clinical and laboratory findings of newborns born to mothers with COVID-19. Thirty pregnant women with COVID-19 were admitted to Turgut Ozal University Hospital for delivery. Fourteen pregnant women had at least one symptom associated with COVID-19. Positive polymerase chain reaction (PCR) results were seen in only 3 (9.7%) of 31 newborns. A statistically significant difference was observed between PCR-positive and PCR-negative newborns in terms of any adverse pregnancy outcomes. Neonatal lymphocyte count and partial arterial oxygen pressure were significantly lower in the PCR-positive group. Results were also compared according to the interval from the maternal diagnosis time to delivery. Hemoglobin and hematocrit levels in newborns born to mothers diagnosed more than 7 days before delivery were significantly lower. Neonates born to mothers with COVID-19 had mild clinical symptoms and favorable outcomes.eninfo:eu-repo/semantics/openAccessCOVID-19pregnancyneonatal outcomesArticle6121771833479674010.1177/000992282110598862-s2.0-85119531708Q2WOS:000721499500001Q4